Review
doi: 10.1111/j.1365-2141.2005.05769.x.
Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Affiliations
- PMID: 16351634
- DOI: 10.1111/j.1365-2141.2005.05769.x
Item in Clipboard
Review
Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Br J Haematol.
2005 Dec.
Abstract
National guidelines for platelet transfusion in many countries recommend that the general platelet transfusion trigger for prophylaxis is 10x10(9)/l. This annotation reviews the evidence for this threshold level and discusses other current unresolved issues relevant to platelet transfusion practice such as the optimal dose and the clinical benefit of a strategy for the prophylactic use of platelet transfusions when the platelet count falls below a given threshold.
Similar articles
-
Platelet transfusions for patients with haematological malignancies: who needs them?Br J Haematol. 2011 Aug;154(4):425-40. doi: 10.1111/j.1365-2141.2010.08483.x. Epub 2011 May 25. Br J Haematol. 2011. PMID: 21615375 Review.
-
Compliance with prophylactic platelet transfusion trigger in haematological patients.Transfus Med. 2005 Feb;15(1):45-8. doi: 10.1111/j.1365-3148.2005.00547.x. Transfus Med. 2005. PMID: 15713128
-
Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.Blood Rev. 2011 May;25(3):113-22. doi: 10.1016/j.blre.2011.01.006. Epub 2011 Feb 12. Blood Rev. 2011. PMID: 21316823 Review.
-
Thrombocytopenia and platelet transfusions in patients with cancer.Cancer Treat Res. 2011;157:251-65. doi: 10.1007/978-1-4419-7073-2_15. Cancer Treat Res. 2011. PMID: 21052961 Review.
-
Platelet utilization and the transfusion trigger: a prospective analysis.Transfusion. 2007 Feb;47(2):201-5. doi: 10.1111/j.1537-2995.2007.01089.x. Transfusion. 2007. PMID: 17302764
Cited by
-
Dose-dependent effect of canine lyophilized platelet on an in vitro hemodilution model.BMC Vet Res. 2023 Mar 17;19(1):61. doi: 10.1186/s12917-023-03614-3. BMC Vet Res. 2023. PMID: 36932415 Free PMC article.
-
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3. Cochrane Database Syst Rev. 2012. PMID: 22592695 Free PMC article.
-
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.Cochrane Database Syst Rev. 2014;(3):CD010981. doi: 10.1002/14651858.CD010981. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Sep 30;(9):CD010981. doi: 10.1002/14651858.CD010981.pub2. PMID: 25722649 Free PMC article. Updated.
-
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.Cochrane Database Syst Rev. 2015 Oct 27;2015(10):CD010984. doi: 10.1002/14651858.CD010984.pub2. Cochrane Database Syst Rev. 2015. PMID: 26505729 Free PMC article.
-
Recommendations for the transfusion of plasma and platelets.Blood Transfus. 2009 Apr;7(2):132-50. doi: 10.2450/2009.0005-09. Blood Transfus. 2009. PMID: 19503635 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
